April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
The Burden Of Refractive Error In China
Author Affiliations & Notes
  • Danny S. Ng
    Ophthalmology, Tung Wah Eastern Hospital, Hong Kong, Hong Kong, Hong Kong
  • Clement W. Chan
    Ophthalmology, Tung Wah Eastern Hospital, Hong Kong, Hong Kong, Hong Kong
  • Mingguang He
    Preventive Ophthalmology, Zhongshan Ophthalmic Center, Guangzhou, China
  • Leon Ellwein
    NEI, Bethesda, Maryland
  • Jialiang Zhao
    PUMC, Beijing, China
  • Paul Glewwe
    Applied Economics, University of Minnesota, St Paul, Minnesota
  • Xiang Lu
    Ophthalmology, Tongren, Beijing, China
  • Ningli Wang
    Ophthalmology, Tongren, Beijing, China
  • Benita O'Colmain
    ICF Macro, Calverton, Maryland
  • Nathan G. Congdon
    Preventive Ophthalmology, Zhongshan Ophthalmic Center, Guangzhou, China
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2520. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Danny S. Ng, Clement W. Chan, Mingguang He, Leon Ellwein, Jialiang Zhao, Paul Glewwe, Xiang Lu, Ningli Wang, Benita O'Colmain, Nathan G. Congdon; The Burden Of Refractive Error In China. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2520.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : WHO reports 46% of world vision impairment from refractive error (RE) among children occurs in China. We estimated RE prevalence and associated vision impairment (VI) among Chinese children and adults.

Methods: : Data from population-based studies were stratified by gender in age intervals of 3 years (ages 3-17 y) or 10 years (ages >= 30 y): counts of persons with myopia (worse eye spherical equivalent <= -1.0D, <= -2.0D, <= -6.0D) and prevalence of low vision (< 6/12 in the better-seeing eye for children and < 6/18 for adults) and blindness (<=6/60) attributable to RE. Figures for VI included persons with habitual vision below the cutoff improving to above the cutoff with refraction, and those with myopic retinopathy. Estimates for ages 18-29 y were obtained from regression models derived from the pooled estimates. Prevalence of myopia and VI attributable to RE in each age/gender category was calculated by applying modeled rates to 2000 China census figures and projections for 2020. Association with VI attributable to RE was tested for: gender, urban versus rural residence, and residence in provinces with per capita GDP in the upper versus lower 50% for China.

Results: : Data were obtained from 5 cohorts for children and 14 for adults. There were 291 million and 21.4 million persons with myopia <= -1.0D and <= -6.0D respectively in 2000, expected to rise to 306 million and 36.9 million by 2020. Of these, 18.4 million were blind and 116 million had low vision in 2000, with figures of 25.3 million and 123 million in 2020. Children accounted for the following proportion of RE disease burden in China in 2000: myopia <= -1.0D: 19.0%; RE-associated low vision: 56.1%; blindness: 14.1%. Refractive error was responsible for 82.3% of blindness and 90.5% of low vision among children, and 11.6% and 64.4% of blindness and low vision among adults. Urban residence (OR 1.85, P = 0.004)and higher GDP (OR 10.6, P < 0.001) were associated with refractive blindness among children. For adults, lower GDP was associated with refractive blindness (OR 1.47, P = 0.01). Gender was un-associated with refractive blindness among children or adults.

Conclusions: : Both children and adults suffer a heavy burden of VI associated with RE in China. Income may affect risk for such VI differently among children and adults.

Keywords: clinical (human) or epidemiologic studies: prevalence/incidence • clinical (human) or epidemiologic studies: risk factor assessment • myopia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×